These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3873216)

  • 1. Comparative in vitro activities of twelve antimicrobial agents against Campylobacter species.
    Fliegelman RM; Petrak RM; Goodman LJ; Segreti J; Trenholme GM; Kaplan RL
    Antimicrob Agents Chemother; 1985 Mar; 27(3):429-30. PubMed ID: 3873216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of clinical isolates of Campylobacter jejuni to twenty-five antimicrobial agents.
    Lariviere LA; Gaudreau CL; Turgeon FF
    J Antimicrob Chemother; 1986 Dec; 18(6):681-5. PubMed ID: 3493235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents.
    Vanhoof R; Vanderlinden MP; Dierickx R; Lauwers S; Yourassowsky E; Butzler JP
    Antimicrob Agents Chemother; 1978 Oct; 14(4):553-6. PubMed ID: 718153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of Campylobacter jejuni to twenty-three antimicrobial agents.
    Shanker S; Sorrell TC
    Pathology; 1983 Jan; 15(1):61-3. PubMed ID: 6602320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Campylobacter fetus subsp. jejuni to twenty antimicrobiol agents.
    Walder M
    Antimicrob Agents Chemother; 1979 Jul; 16(1):37-9. PubMed ID: 475372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of Campylobacter jejuni and Campylobacter coli isolated in Denmark to fourteen antimicrobial agents.
    Andreasen JJ
    Acta Pathol Microbiol Immunol Scand B; 1987 Jun; 95(3):189-92. PubMed ID: 3630712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of Campylobacter fetus subsp. jejuni to N-formimidoyl thienamycin, rosaramicin, cefoperazone, and other antimicrobial agents.
    Ahonkhai VI; Cherubin CE; Sierra MF; Bokkenheuser VD; Shulman MA; Mosenthal AC
    Antimicrob Agents Chemother; 1981 Dec; 20(6):850-1. PubMed ID: 6459767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EUCAST recommendations for antimicrobial susceptibility testing applied to the three main Campylobacter species isolated in humans.
    Sifré E; Salha BA; Ducournau A; Floch P; Chardon H; Mégraud F; Lehours P
    J Microbiol Methods; 2015 Dec; 119():206-13. PubMed ID: 26519770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of clinical isolates of Campylobacter jejuni to sixteen antimicrobial agents.
    Michel J; Rogol M; Dickman D
    Antimicrob Agents Chemother; 1983 May; 23(5):796-7. PubMed ID: 6870228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic resistance in campylobacter jejuni/coli from human and animal sources.
    Naeem K; Macaulay ME
    J Pak Med Assoc; 1983 Apr; 33(4):91-4. PubMed ID: 6410091
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimicrobial resistance of Campylobacter jejuni and Campylobacter coli with special reference to plasmid profiles of Japanese clinical isolates.
    Sagara H; Mochizuki A; Okamura N; Nakaya R
    Antimicrob Agents Chemother; 1987 May; 31(5):713-9. PubMed ID: 3038005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriostatic and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp. jejuni.
    Vanhoof R; Gordts B; Dierickx R; Coignau H; Butzler JP
    Antimicrob Agents Chemother; 1980 Jul; 18(1):118-21. PubMed ID: 7416738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibilities to 10 antimicrobial agents of 1,220 Campylobacter strains isolated from 1987 to 1993 from feces of pediatric patients.
    Reina J; Ros MJ; Serra A
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2917-20. PubMed ID: 7695284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors.
    Tajada P; Gomez-Graces JL; Alós JI; Balas D; Cogollos R
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1924-5. PubMed ID: 8843305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of Campylobacter fetus subsp. jejuni, isolated from patients in Jakarta, Indonesia to ten antimicrobial agents.
    Ringertz S; Rockhill RC; Ringertz O
    J Antimicrob Chemother; 1981 Oct; 8(4):333-6. PubMed ID: 7298551
    [No Abstract]   [Full Text] [Related]  

  • 16. Campylobacter spp antibiotic susceptibility.
    Navarro F; Miró E; Mirelis B; Prats G
    J Antimicrob Chemother; 1993 Dec; 32(6):906-7. PubMed ID: 8144435
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro susceptibility of Campylobacter jejuni and Campylobacter coli isolated in Austria to erythromycin and ciprofloxacin.
    Hirschl AM; Wolf D; Berger J; Rotter ML
    Zentralbl Bakteriol; 1990 Apr; 272(4):443-7. PubMed ID: 2360966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of Campylobacter species to nalidixic acid, enoxacin, and other DNA gyrase inhibitors.
    Taylor DE; Ng LK; Lior H
    Antimicrob Agents Chemother; 1985 Nov; 28(5):708-10. PubMed ID: 3004325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of antimicrobial susceptibility patterns of Campylobacter jejuni and Campylobacter coli.
    Wang WL; Reller LB; Blaser MJ
    Antimicrob Agents Chemother; 1984 Sep; 26(3):351-3. PubMed ID: 6508265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoresistances among 80 Campylobacter strains isolated from childhood gastroenteritis cases.
    Figura N; Rossi P; Marri L
    Microbiologica; 1985 Apr; 8(2):191-6. PubMed ID: 4010528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.